DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Pentostatin
Pentostatin
Summary of Product Characteristics
Cancer Drug Pharmacology Table
Program Slides
Association of Oral Anticoagulants and Proton Pump Inhibitor Cotherapy with Hospitalization for Upper Gastrointestinal Tract Bleeding
2015 Antiemesis.Pdf
Systemic Therapy Update
Standard Oncology Criteria C16154-A
NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012
CYTOTOXIC and NON-CYTOTOXIC HAZARDOUS MEDICATIONS
Characterization of the Antiyeast Compound and Probiotic Properties
The Cost Burden of Blood Cancer Care a Longitudinal Analysis of Commercially Insured Patients Diagnosed with Blood Cancer
Cancer Drug Costs for a Month of Treatment at Initial Food
(NCCN Guidelines®) Non-Hodgkin's Lymphomas
Acronyms for Oncology Regimens
Patient Information
Prophylaxis Guidelines for the Adult Hematology Patient
Long-Term Outcome with Pentostatin Treatment in Hairy Cell Leukemia Patients
Chemotherapy Protocol HAIRY CELL LEUKEMIA PENTOSTATIN
Top View
How to Order Chemotherapy at Shands at the University of Florida - Inpatient
Management of Extravasation of a Systemic Anti-Cancer Therapy Including Cytotoxic Agents
Intensive Induction Chemotherapy Followed by Early High-Dose
Emetogenic Potential of Antineoplastic Agents
DRUG NAME Toxicities: Acute: Delayed: Subclass Enzyme/Antigen
Chemotherapy-Induced Peripheral Neuropathy: a Literature Review Neuropatia Periférica Induzida Por Quimioterapia: Uma Revisão De Literatura
Adult Antiemetic Management of Chemotherapy-Induced Nausea
The Immunomodulatory Effects of Arsenic Trioxide in Autoimmunity and Alloreactivity Yishan Ye
North Carolina Division of Health Benefits Physician Administered Drug Program Catalog
NIPENT™ (Pentostatin for Injection)
Abbreviated Title: LMB-100 + Abrx in PDA Version Date: 12/11/2018
Supergen Announces Results from Combination Study in CLL Published in the Journal of Clinical Oncology
Target-Centered Drug Repurposing Predictions of Human Angiotensin
Pentostatin: High-Dose (Nipent®) | UPMC Hillman Cancer Center
BHS Guidelines for the Treatment of Large Granular Lymphocyte and Chronic Prolymphocytic Leukaemias
Cancer Drug Costs for a Month of Treatment at Initial Food and Drug
[2016]. NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016
Download Master-Thesis
Cancer Drug Costs for a Month of Treatment at Initial Food and Drug Administration Approval
Year of FDA Monthly Cost Approval
NIOSH Alert: Preventing Occupational Exposures to Antineoplastic
Symptom Management Myelosuppression Grading
Pentostatin Plus Cyclophosphamide Safely and Effectively Prevents Immunotoxin Immunogenicity in Murine Hosts
Vivida Health Specialty Pharmacy Drugs (Injectable) Prior-Authorization Requirements Effective 1/1/19
Oncology Medications and Supportive Agents Require Review by New
Chemotherapy Diluent-Rate Guide
The Antimetabolites
Pentostatin (Hairy Cell Leukaemia)
Low-Dose Methotrexate Prevents Primary and Secondary Humoral Immune Responses and Induces Immune Tolerance to a Recombinant Immu
Specialty Pharmacy
Pentostatin (Interim Monograph)
Open PDF File, 200.95 KB, for Pharmacy Facts 77 (March 14, 2013)
Hazardous Drug List
Methotrexate an Old Drug with New Tricks
Medications That Are Considered Hazardous
Long-Term Follow-Up of 233 Patients with Hairy Cell Leukaemia, Treated Initially with Pentostatin Or Cladribine, at a Median of 16 Years from Diagnosis
BC CANCER CHEMOTHERAPY PREPARATION and STABILITY CHART DRUG & STRENGTH (Storage Prior to Use, Manufacturer, Preservative
Antineoplastic Drugs